Bryn Mawr Capital Management LLC Purchases 15,662 Shares of The Chemours Company (NYSE:CC)

Bryn Mawr Capital Management LLC raised its position in The Chemours Company (NYSE:CCFree Report) by 135.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 27,205 shares of the specialty chemicals company’s stock after acquiring an additional 15,662 shares during the period. Bryn Mawr Capital Management LLC’s holdings in Chemours were worth $858,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Legacy Financial Group LLC bought a new stake in Chemours in the 3rd quarter valued at approximately $29,000. Morton Brown Family Wealth LLC acquired a new position in shares of Chemours during the 4th quarter worth approximately $35,000. Anchor Investment Management LLC acquired a new position in shares of Chemours during the 4th quarter worth approximately $56,000. Geneos Wealth Management Inc. increased its position in shares of Chemours by 116.4% during the 4th quarter. Geneos Wealth Management Inc. now owns 1,859 shares of the specialty chemicals company’s stock worth $59,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Bfsg LLC acquired a new position in shares of Chemours during the 4th quarter worth approximately $62,000. Institutional investors own 76.26% of the company’s stock.

Chemours Price Performance

CC stock opened at $27.32 on Friday. The company has a debt-to-equity ratio of 5.40, a current ratio of 1.54 and a quick ratio of 1.00. The Chemours Company has a 1-year low of $15.10 and a 1-year high of $39.05. The business’s 50 day simple moving average is $26.72 and its 200 day simple moving average is $27.79.

Chemours (NYSE:CCGet Free Report) last posted its earnings results on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. Chemours had a positive return on equity of 51.73% and a negative net margin of 3.80%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. As a group, analysts expect that The Chemours Company will post 2.23 EPS for the current fiscal year.

Chemours Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 3.66%. The ex-dividend date of this dividend was Friday, February 23rd. Chemours’s dividend payout ratio is -64.52%.

Wall Street Analysts Forecast Growth

CC has been the topic of several recent analyst reports. UBS Group boosted their price target on Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 2nd. Barclays lowered their price target on Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 2nd. Finally, BMO Capital Markets raised Chemours from an “underperform” rating to an “outperform” rating and boosted their price target for the stock from $19.00 to $34.00 in a research report on Tuesday, April 9th. Seven analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $30.89.

Get Our Latest Stock Report on CC

Chemours Company Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Articles

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.